Paper499319
Influence of the defective metabolism of sparteine on its pharmacokinetics.
Eichelbaum M and 2 others. Eur J Clin Pharmacol, 1979. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Influence of the defective metabolism of sparteine on its pharmacokinetics. Papers, record 499319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/499319
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sparteine | Major topic |
| Adult | |
| Biotransformation | |
| Half-Life | |
| Humans | |
| Kidney | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Phenotype | |
| Time Factors |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 499318 | Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. | Eur J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/499318 | PubMed |
| 2 | 4408126 | [The chemistry of sparteins]. | Arzneimittelforschung | 1974 | https://conductscience.org/library/papers/4408126 | PubMed |
| 3 | 14301017 | EFFECTS OF AUTONOMIC DRUGS ON RENAL TUBULAR TRANSPORT OF CATECHOLAMINES IN THE CHICKEN. | J Pharmacol Exp Ther | 1965 | https://conductscience.org/library/papers/14301017 | PubMed |
| 4 | 14432197 | Renal tubular excretion of organic bases. | Pharmacol Rev | 1960 | https://conductscience.org/library/papers/14432197 | PubMed |
| 5 | 5411325 | Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. | J Pharm Sci | 1970 | https://conductscience.org/library/papers/5411325 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32626161 | Scientific opinion on the risks for animal and human health related to the presence of quinolizidine alkaloids in feed and food, in particular in lupins and lupin-derived products. | EFSA J | 2019 | https://conductscience.org/library/papers/32626161 | PubMed |
| 30677473 | Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity. | Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30677473 | PubMed |
| 24913012 | Addressing phenoconversion: the Achilles' heel of personalized medicine. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/24913012 | PubMed |
| 19817501 | Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. | Clin Pharmacokinet | 2009 | https://conductscience.org/library/papers/19817501 | PubMed |
| 18026129 | Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18026129 | PubMed |
| 16771600 | The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. | Mol Diagn Ther | 2006 | https://conductscience.org/library/papers/16771600 | PubMed |
| 15492763 | Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. | Pharmacogenomics J | 2005 | https://conductscience.org/library/papers/15492763 | PubMed |
| 12728290 | Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects. | Eur J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/12728290 | PubMed |
| 7988103 | Assessment of liver metabolic function. Clinical implications. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/7988103 | PubMed |
| 7371707 | Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7371707 | PubMed |
| 7042170 | Defective oxidation of drugs: pharmacokinetic and therapeutic implications. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/7042170 | PubMed |
| 6754206 | Ethnic differences in drug metabolism. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/6754206 | PubMed |
| 3780830 | Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3780830 | PubMed |
| 3768256 | Sparteine oxidation polymorphism in Greenlanders living in Denmark. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3768256 | PubMed |
| 3741726 | The influence of enzyme induction on polymorphic sparteine oxidation. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3741726 | PubMed |
| 2744072 | Determination of dextromethorphan metabolizer phenotype in healthy volunteers. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2744072 | PubMed |
| 2686883 | Clinical pharmacokinetic considerations in the elderly. An update. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2686883 | PubMed |
| 2570698 | Clinical significance of the sparteine/debrisoquine oxidation polymorphism. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2570698 | PubMed |
| 2182263 | Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2182263 | PubMed |
| 499318 | Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. | Eur J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/499318 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/499319
GET https://conductscience.org/api/papers/v1/499319/authors